about
A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial.The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes.Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes.Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.The PPARγ2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathyArterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetesEvaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathyTelomere length predicts all-cause mortality in patients with type 1 diabetesSoluble CD40 ligand is elevated in Type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney functionPlasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathySerum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy
P50
Q30437335-335B0E2F-6824-453B-AAC7-F0BA8E4FF757Q30978054-3F856AA4-4B9E-49C3-B9ED-D949BC85E9E0Q33932770-7A411DDC-0C42-410F-B0AE-662487B82424Q34024272-D20C8168-F0FD-41E0-B0B5-D6C07D838C48Q34507243-3037636F-4754-41D1-A71C-E89EDA590D79Q36138225-EEC2DFAB-3DC1-44E8-865C-64D82FAC50B6Q41691235-131049D2-6241-44C1-B234-BE95AF1F592FQ43260352-38D8181B-6B7C-42A5-A902-9B90855F23F9Q43824471-967C5882-9748-4AB4-AE0C-DA8BB82DA739Q44617933-9A550C61-5FCA-4220-A2DE-4CC4D12FAAFCQ45949352-0C4B50C1-2CE8-4CDD-BC8E-89A405D6342DQ46107580-1104BBDF-DFA9-46A5-91D3-6C0E67998A25Q47722271-927F1B29-EE67-4EB1-8A99-272E410A9EC4Q48136986-0FF6AAC6-8F8F-4200-B7A9-4C58DA2AC75DQ57737184-AC4F8D6E-4D17-47EE-9D5F-49CD4B717A15Q59489200-F5B58F73-FC5D-4399-8FED-084D7F1AC5EDQ59489204-20E14017-C9B4-47ED-8022-07A13D9D9D7BQ59489211-B6C486A4-EA26-42B8-89E1-0F7249E7CD3BQ59489215-A9CD9854-D4B7-4E93-A4A6-B07FC45D259CQ59489227-7EF3DE67-EF26-422A-B882-E165115A6C02Q59489228-E96EEA85-E8AE-463E-A4A8-B9F8E19A9104
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anders Jorsal
@ast
Anders Jorsal
@en
Anders Jorsal
@es
Anders Jorsal
@nl
type
label
Anders Jorsal
@ast
Anders Jorsal
@en
Anders Jorsal
@es
Anders Jorsal
@nl
prefLabel
Anders Jorsal
@ast
Anders Jorsal
@en
Anders Jorsal
@es
Anders Jorsal
@nl
P106
P1153
24168825800
P21
P31
P496
0000-0002-1969-4255